Literature DB >> 11221742

Comments on diet and compliance in phenylketonuria.

R O Fisch1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11221742     DOI： 10.1007/pl00014378

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.

Authors:  Christineh N Sarkissian; Tse Siang Kang; Alejandra Gámez; Charles R Scriver; Raymond C Stevens
Journal:  Mol Genet Metab       Date:  2011-06-29       Impact factor: 4.797

2.  Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.

Authors:  Christineh N Sarkissian; Alejandra Gámez; Lin Wang; Marilyse Charbonneau; Paul Fitzpatrick; Jeffrey F Lemontt; Bin Zhao; Michael Vellard; Sean M Bell; Carroll Henschell; Amy Lambert; Laurie Tsuruda; Raymond C Stevens; Charles R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

3.  Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.

Authors:  Nicola Longo; Cary O Harding; Barbara K Burton; Dorothy K Grange; Jerry Vockley; Melissa Wasserstein; Gregory M Rice; Alejandro Dorenbaum; Jutta K Neuenburg; Donald G Musson; Zhonghua Gu; Saba Sile
Journal:  Lancet       Date:  2014-04-14       Impact factor: 79.321

4.  Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in Iran.

Authors:  Aria Setoodeh; Bahram Yarali; Ali Rabbani; Shohreh Khatami; Sedigheh Shams
Journal:  Mol Genet Metab Rep       Date:  2015-01-28

5.  Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.

Authors:  William L Zeile; Helen C McCune; Donald G Musson; Brian O'Donnell; Charles A O'Neill; Laurie S Tsuruda; Roberto T Zori; Philip J Laipis
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

6.  Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.

Authors:  Sean M Bell; Dan J Wendt; Yanhong Zhang; Timothy W Taylor; Shinong Long; Laurie Tsuruda; Bin Zhao; Phillip Laipis; Paul A Fitzpatrick
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

7.  One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4).

Authors:  Kristen D Brantley; Teresa D Douglas; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2018-10-30       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.